Skip to main content
. Author manuscript; available in PMC: 2015 Mar 16.
Published in final edited form as: J Infect Dis. 1999 Jun;179(6):1395–1404. doi: 10.1086/314764

Figure 2.

Figure 2

Cumulative rates (and 95% confidence intervals) of (A) Epstein-Barr virus (EBV) infection (defined as youngest age of either first oropharyngeal shedding or age at EBV seroconversion) and (B) EBV seroconversion alone of human immunodeficiency virus type 1–infected children identified as rapid progressors or as nonrapid progressors for first 3 years of life.